Introduction
There are several principles of informed consent for patients having cataract surgery with refractive intraocular lenses (IOLs) that are similar to the principles recommended for patients undergoing elective refractive surgery. With the advent of these new lenses, the distinction between a refractive and cataract surgeon has become increasingly blurred. Every patient requiring cataract surgery is now a potential refractive surgery patient. Furthermore, cataract surgeons are ethically obligated to inform their cataract patients about the pros and cons of these new lenses, including what patients can and cannot expect from them in terms of postoperative vision and other options that may be available. Patients should be informed that they will not have clear uncorrected vision at all distances with these lenses. This translates into more one-on-one counseling of patients, requiring significantly more 'chair' time than with the more routine cataract patients of the past [1] .
Informed consent background
Ophthalmologists are familiar with the legal and ethical obligation to obtain the patient's informed consent before any surgical procedure. The patient's consent must be both voluntary and informed, and obtained in advance of surgery, when the patient is able to participate in the decision-making process in a meaningful way. Too often equated with simply a consent form, appropriate informed consent is a process which begins as an oral agreement between the ophthalmologist and the patient that is reached after a personal discussion. The discussion includes a description of the condition, recommended treatment or procedure, and the risks, benefits, complications, and alternatives, as well as the consequences of refusing the recommended treatment or procedure.
Unless the surgeon performs a procedure that is different from what is discussed and described or is in addition to the one discussed with the patient [i.e. limbal relaxing incision (LRI) during cataract surgery], lack of informed consent is rarely the main focus of lawsuits [2] . Nonetheless, plaintiff attorneys and juries alike always pay close attention to this issue. Allegations often include failure to warn the patient of a particular complication for which the patient is at increased risk, coerced consent obtained the day of surgery, or the patient's incapacity to give consent when medicated. Lack of documentation of the consent discussion inevitably leads to a credibility Purpose of review With the introduction of several new intraocular lenses into the US ophthalmology market over the past several years, the importance of the informed consent process has significantly increased for all cataract surgeons. Managing unrealistic patient expectations is paramount in reducing the medico-legal risk associated with these procedures.
Recent findings
Increased emphasis on the informed consent process is intended to promote patient safety and reduce liability exposure when performing cataract or refractive lens exchange surgery. Particular attention to preoperative counseling, careful patient selection, and timing of the informed consent process are key elements in successfully managing the medico-legal risk associated with these surgical procedures. Summary The new intraocular lens options for correcting both near and distant vision through cataract surgery raise important risk management and informed consent issues for the ophthalmologist. As long as the informed consent process has been performed appropriately and is well documented in the medical record and the risk/benefit ratio of the specific procedure for a given patient is favorable, the decision to proceed with surgery should be considered sound. issue. To honor the patient's right to make decisions about healthcare, ensure patient understanding, and prevent allegations of lack of informed consent, a few general guidelines are important.
In general, the healthcare provider performing the diagnostic procedure or surgery must obtain informed consent for it. The duty to obtain informed consent cannot be delegated. This advice is particularly important for surgeons who co-manage patients; in addition to obtaining consent, they would be well advised to perform their own independent evaluation of the patient's candidacy and to ask the patient to sign a written consent for the comanagement. If the patient has any known risk factors that increase the likelihood of complications, side effects, or poor outcome, the ophthalmologist should discuss these specific issues with the patient. The informed consent discussion should take place when the patient is awake and alert, free from the effects of any medication that could interfere with the patient's ability to participate in the decision-making process.
For elective surgeries, the discussion should take place prior to the day of the surgery, whenever possible. Some patients who had surgery the same day as the informed consent discussion have later sued for lack of informed consent, arguing that they were coerced into having the procedure and did not have time to weigh the risks and benefits. If the patient cannot be seen until the day of surgery due to time and distance travel constraints, but the type of surgery is already determined, taking a few additional steps in the informed consent process will facilitate patient understanding and help ensure that consent is based on pertinent and important facts and is voluntary. These include obtaining information about the patient's medical and ocular health from the referring physician or directly from the patient per telephone or questionnaire. This is needed to rule out medical contraindications to the procedure and screen for conditions that could affect the safety of the surgery or anesthesia. Another option is to send the patient an unsigned copy of the procedure-specific form along with other educational information, and asking the patient to review the materials well in advance of surgery. Documenting this step in the medical record is extremely important from a risk management perspective.
The informed consent discussion and process should always be documented, ideally in two ways. First, the surgeon should include a brief note about the discussion in the medical record. If the discussion took place in a language other than English, document the language used, and the name and relationship of any translator. Specific questions or concerns raised by the patient should be documented, along with the answers. In addition to documenting that the discussion took place, patients should sign a procedure-specific consent form, and be given a copy for review with family or legal guardian. Records and copies of educational materials distributed to patients should be kept readily available.
Preoperative counseling of patients
Several new IOLs have been introduced into the US ophthalmology market over the past several years with technological features described as accommodating, apodized diffractive, or presbyopia correcting [3 ] . These lenses correct for all ranges of vision -near, intermediate, and distance. The new IOL options for correcting both near and distant vision via cataract or refractive lens exchange (RLE) surgery raise important risk management and informed consent issues for the ophthalmologist.
It is important to discuss with patients what it means for an IOL to be FDA-approved and how it is intended to be used. If the lens was recently approved, surgeons need to inform patients about the lack of long-term outcomes and experience with the lens and advise them that unanticipated problems may possibly occur. For RLE procedures, surgeons should advise patients that the procedure is considered to be off-label and a full explanation of what 'off-label' means should be discussed with the patient. This discussion should be clearly documented in the patient's medical record.
The informed consent should include a detailed description of alternatives to RLE. A dialogue with patients about presbyopia and the options for near and/or distance vision correction should occur. Patients should not feel under any pressure to choose one option over another. Furthermore, patients appreciate the additional explanation regarding the rationale for your recommendation. Options that patients should be made aware of include monofocal IOLs, reading glasses, monovision, and multifocal IOLs.
Disclose and document the option of monovision and demonstrate what a patient's postoperative vision may be like using a contact lens or glasses. If the patient refuses a short-term trial of monovision, document this in the medical record. If the patient agrees to pursue monovision, explain the possible difficulties with depth perception, diplopia, and potential balance issues. This is the value of having the patient wear a contact lens in one eye for a short period of time to simulate the monovision condition. Although popular with many patients, there are others who simply cannot tolerate monovision.
With multifocal IOLs, one should explain that the goal is to reduce the patient's dependency on glasses or contact lenses for both distance and near vision, but that there is no guarantee that this goal can be fully achieved. The Informed consent in cataract surgery Abbott 53 objective of a multifocal IOL is to restore some or all of the near (and intermediate, depending upon the IOL) focusing ability, but other factors may affect postoperative outcomes (e.g. IOL power, IOL position, wound healing, functioning of the ciliary muscle).
Side effects associated with multifocal IOLs may include less sharp vision, worse vision in dim light, halos around lights, decreased contrast sensitivity, and difficulty driving at night. Patients need to be informed of all these possibilities. Furthermore, one must explain that, if an intraoperative complication occurs, a monofocal IOL may have to be implanted instead of the scheduled multifocal lens.
Patients also need to know whether laser-assisted in-situ keratomileusis (LASIK) and/or photorefractive keratectomy (PRK) is available in the same office if additional correction is required following RLE. If the surgery center does not offer these procedures, the surgeon should be ready to provide the patient with a list of refractive surgeons in the area. Also, patients must be told whether refractive surgery, spectacles, or other forms of correction, if required, are included in the global fee for the cataract surgery with a multifocal IOL.
Another important clinical issue to discuss are the potential risks of retinal detachment in high myopes. There is a high risk for retinal detachment, especially in a younger patient with high myopia undergoing a clear lens extraction or a RLE. The peripheral retina should be examined very carefully preoperatively, and, if the surgeon is not comfortable in doing scleral depression of the peripheral retina, these patients should be referred to a retinal specialist for a careful examination.
Sometimes during surgery, the refractive lens chosen for insertion cannot be placed due to intraoperative issues. This risk needs to be discussed prior to surgery, especially in those patients at risk for such complications (e.g. capsule rupture in a patient with pseudoexfoliation). That this topic was addressed during preoperative counseling should be documented in the patient's medical record.
Inappropriate patients for multifocal lenses
A patient's preoperative unrealistic expectations may often present as a significant problem following a less than 'perfect' outcome for cataract and IOL surgery. During the informed consent process, verbally emphasize to patients that they may not achieve a specific postoperative visual acuity with the selected IOL. The selection of a proper implant for a specific patient is based upon sophisticated equipment and a computer formula, but it is not an exact science. Let patients know that, if a postoperative refractive result is considerably different, eyeglasses, refractive surgery, or repositioning or replacement of the IOL may be required. Discussion of the costs related to these procedures should also be clearly explained both verbally and in writing so that there is no misunderstanding if these are required. If the patient has difficulty in accepting this possible outcome, further counseling with the patient should be pursued and surgery either postponed or canceled.
Communicate to patients that, although surgery may eliminate a cataract, and/or refractive error and presbyopia, it will not correct any potentially sight-threatening condition of the eye (i.e. peripheral retinal degeneration) that may be found in a highly myopic patient. Furthermore, the surgery cannot guarantee to make a patient happy, more popular, or improve their life if they are inherently unhappy. It is true that satisfaction with a successful postoperative outcome can result in short-term happiness, but it will often not cure longstanding issues of depression or dissatisfaction in one's life situation.
To use a well designed questionnaire to identify inappropriate patients is strongly recommended. Discuss with patients their responses and ask them what they expect from the surgery while assessing their emotional stability and reasonableness. Potentially poor candidates for multifocal IOLs are those who drive long distances at night and/or perform detailed work that requires closer focus than just reading. Often, a monofocal IOL with reading glasses may be a better option for these patients.
Patient financial implications
For an accommodating, apodized diffractive, or presbyopia correcting IOL, the beneficiary is responsible for the charge that exceeds that of a conventional monofocal IOL. Patients should be given the Notice of Exclusion from Medicare Benefits [4] and should know that the Centers for Medicare & Medicaid Services (CMS) will only pay for one pair of glasses or contact lenses, if needed, after the implantation of these newer style IOLs. If the lens needs to be removed due to medical complications, CMS will cover the insertion of a conventional IOL as a replacement. Also, make it known that private insurance may or may not pay for a multifocal IOL. Insurance generally does not cover costs of a RLE procedure.
Marketing as a part of the informed consent process
Marketing and advertising include any promotional or informational activity used by an ophthalmic practice and is considered by the courts to be a part of the informed consent process. With the addition of mutifocal implants and RLE procedures, marketing efforts have increased as ophthalmic surgeons promote their new services. It is important to remember, however, that advertising of offlabel use of an FDA-approved device (i.e. multifocal lenses) is not permitted by the FDA or Federal Trade Commission (FTC). Although advertising by physicians remains an acceptable way to market one's practice, it is required by the FTC, many state laws, and the AAO Code of Ethics that all material must not be false or deceptive in the way it is presented to the public. Even advertising that states true facts, but conveys a misleading impression to reasonable consumers, may be considered illegal. Ophthalmologists must be able to substantiate all claims made in their advertising. From a risk-management perspective, any deviation from appropriate marketing and advertising principles could weaken the defensibility of a claim or lawsuit since this information is frequently considered to be part of the initial informed consent process.
Conclusion
Cataract surgery is the most frequently performed ophthalmic procedure in the United States and the source of the majority of medical malpractice claims reported to OMIC (unpublished data). Mostly because of patients' increased postoperative visual expectations, the addition of multifocal IOLs and the RLE procedure has increased the medico-legal risk for the surgeon and requires careful attention to the informed consent process. A comprehensive informed consent process, as well as careful chart documentation, helps to protect the surgeon against many unforeseeable medico-legal risks. A sample informed consent form containing the minimum information that the surgeon should personally disclose to the patient has been developed by OMIC and is available for all ophthalmologists to use by accessing the OMIC website (www.omic.com) [5] . The recommendations for informed consent discussed in this chapter highlight the actions ophthalmologists can take to reduce the likelihood of a legal claim or suit.
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